Get Social With Us

Global trends in mammalian cell culture capacity and biomanufacturing

Presented at: The Swiss Biotech Program at BioPharm America 2011

At the end of the 20th Century, biomanufacturing output was limited by factory capacity and process bottlenecks, so companies launched technology and process initiatives to improve productivity. Today, such improvements, as well as mergers and globalization, have produced overcapacity, controlled by the largest firms, with supply and demand mismatches that can limit smaller companies’ access to production. This presentation reviews trends in industry-wide mammalian cell culture capacity and utilization as well as trends in biomanufacturing technologies to address evolving market requirements.